The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Final results of the phase II AVETUX trial (AIO-KRK-0216).
 
Alexander Stein
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Servier; Servier; Servier; Servier
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); Sanofi (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche; Roche; Roche; Roche
 
Mascha Binder
No Relationships to Disclose
 
Eray Goekkurt
No Relationships to Disclose
 
Sylvie Lorenzen
No Relationships to Disclose
 
Jorge Riera-Knorrenschild
No Relationships to Disclose
 
Reinhard Depenbusch
No Relationships to Disclose
 
Thomas Jens Ettrich
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Sanofi; Sanofi; Sanofi; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Sanofi; Sanofi; Sanofi; Sanofi
Research Funding - Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen; Ipsen; Ipsen; Ipsen; Ipsen; Ipsen; Ipsen; Ipsen
 
Steffen Doerfel
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - IKF Klinische Krebsforschung; IKF Klinische Krebsforschung; IKF Klinische Krebsforschung; IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Nordic Bioscience; Nordic Bioscience; Nordic Bioscience; Nordic Bioscience; Roche; Roche; Roche; Roche
Speakers' Bureau - AIO gGmbH; AIO gGmbH; AIO gGmbH; AIO gGmbH; Celgene; Celgene; Celgene; Celgene; Forum für Medizinische Fortbildung; Forum für Medizinische Fortbildung; Forum für Medizinische Fortbildung; Forum für Medizinische Fortbildung; Lilly; Lilly; Lilly; Lilly; MCI group; MCI group; MCI group; MCI group; Nordic Bioscience; Nordic Bioscience; Nordic Bioscience; Nordic Bioscience; Promedior; Promedior; Promedior; Promedior; Roche; Roche; Roche; Roche
Research Funding - Celgene; Celgene; Celgene; Celgene; Federal Ministry of Education and Research; Federal Ministry of Education and Research; Federal Ministry of Education and Research; Federal Ministry of Education and Research; German Cancer Aid; German Cancer Aid; German Cancer Aid; German Cancer Aid; German Research Foundation; German Research Foundation; German Research Foundation; German Research Foundation; Hospira; Hospira; Hospira; Hospira; Lilly; Lilly; Lilly; Lilly; Medac; Medac; Medac; Medac; Merck; Merck; Merck; Merck; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Vifor Pharma; Vifor Pharma; Vifor Pharma; Vifor Pharma
 
Meinolf Karthaus
No Relationships to Disclose
 
Uwe Pelzer
No Relationships to Disclose
 
Donjete Simnica
No Relationships to Disclose
 
Lisa Waberer
No Relationships to Disclose
 
Axel Hinke
Honoraria - Roche Pharma AG; Roche Pharma AG; Roche Pharma AG; Roche Pharma AG
 
Carsten Bokemeyer
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Servier/Pfizer; Servier/Pfizer; Servier/Pfizer; Servier/Pfizer
Consulting or Advisory Role - AOK Health Insurance; AOK Health Insurance; AOK Health Insurance; AOK Health Insurance; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; GSO; GSO; GSO; GSO; Hexal; Hexal; Hexal; Hexal; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Mundipharma; Mundipharma; Mundipharma; Mundipharma; Sanofi; Sanofi; Sanofi; Sanofi
Research Funding - several companies in coooperation for clincal studies and for preclinical laboratory work (at my institution more than 100 ongoing reserach projects) (Inst); several companies in coooperation for clincal studies and for preclinical laboratory work (at my institution more than 100 ongoing reserach projects) (Inst); several companies in coooperation for clincal studies and for preclinical laboratory work (at my institution more than 100 ongoing reserach projects) (Inst); several companies in coooperation for clincal studies and for preclinical laboratory work (at my institution more than 100 ongoing reserach projects) (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Pfizer; Pfizer; Pfizer; Pfizer; Sanofi; Sanofi; Sanofi; Sanofi
 
Susanna Hegewisch-Becker
No Relationships to Disclose